ESTA (Motiva) Company Projected Revenue
The implementation of RFID chips and Mia tools is driving growth, as confirmed by Establishment Labs (ESTA) future sales trajectory. The 0.26 mark characterizes this parameter. Business resilience is based on patents and the safety of Motiva. Expansion into China and the US relies on technological superiority in the premium segment, ensuring long-term development within the aesthetic medicine niche.
Analytical breakdowns and data insights for company Establishment Labs Corp (ESTA)
- current price and projected stock value:
- business market valuation indicators:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Establishment Labs|ESTA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Motiva|ESTA - Company Total Debt|Debts to Book Capitalization Establishment Labs Corp|ESTA - Company Long-Term Debts|Company Short-Term Debt Establishment Labs|Quick Liquidity Indicator establishmentlabs.com
- earnings and market ratios statistics:
ESTA - Final Profit|Projected Future Earnings Establishment Labs|ESTA - Market Cap to Earnings|Future Price to Earnings Establishment Labs Holdings Inc.|ESTA - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio Establishment Labs Corp|ESTA - Operating profit EBITDA|Net earnings per share (EPS TTM) Establishment Labs|ESTA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months establishmentlabs.com|ESTA - Earnings per share trend in current year|Net earnings per share growth forecast for next year Establishment Labs
- sales and revenue data:
Fundamental company analysis:Establishment Labs
Future sales volume assesses the issuer's expected revenue, adapting fundamental forecasts to current market conditions to minimize capital risks. The trend in planned sales proceeds reflects the cash flow's sensitivity to external shocks, which is clearly evidenced by the volatility of the Establishment Labs (ESTA) metric due to supply chain disruptions and export restrictions on medical silicone deliveries.
Analysis of competing companies
Company Future Sales Volume BSX (Boston Scientific)|EW (edwards.com) - Company Future Revenue|Company Projected Revenue ResMed RMD|PODD - Company Future Sales Volume|Zimmer - Projected Sales Volume|Company Expected Sales Volume CooperSurgical|ALGN: Projected Sales Volume|Company Revenue Forecast GMED|TMDX (TransMedics Group, Inc.) - Projected Sales Volume|Alphatec Holdings (ATEC) - Company Future Sales|Projected Sales Volume AORT|Company Future Sales Volume Enovis Inc. ENOV|Projected Sales Volume IART (Integra LifeSciences)|Projected Sales Volume betabionics.com BBNX|IRMD - Company Projected Revenue|EMBC: Company Projected Revenue|TNDM (Tandem Diabetes) - Company Future Sales Volume|Axogen Surgical - Company Future Revenue|SIBN (SI-BONE, Inc.) - Projected Sales Volume|Company Expected Sales Volume orthofix.com OFIX|Company Projected Revenue Bioventus (BVS)|orthopediatrics.com (KIDS) - Company Sales Forecast|Treace Medical - Company Future Sales Volume|Projected Sales Volume Strata Medical SRTA|Carlsmed Inc - Projected Sales Volume|Company Future Sales rxsight.com RXST|clearpointneuro.com (CLPT) - Company Projected Revenue|Company Expected Revenue STXS (Stereotaxis Inc)|Company Projected Revenue NeuroStar|Company Future Sales Volume Sight Sciences Inc (SGHT)|Projected Sales Volume OBIO|ANIK - Company Expected Sales Volume|Company Projected Revenue InspireMD NSPR|ZJYL: Company Revenue Forecast|VANI: Company Future Sales Volume|Xtant Medical Holdings - Company Projected Revenue Volume|NMTC: Projected Sales Volume|Company Expected Sales Volume Modular Medical, Inc. (MODD)|Company Projected Revenue Myomo|Envoy Medical Inc. (COCH) - Company Future Sales|Company Future Sales Volume VVOS (Vivos Therapeutics, Inc)|Company Projected Revenue Volume NVNO|Projected Sales Volume SINT (Sintx Technologies, Inc.)|Projected Sales Volume tenonmed.com TNON|Lifeward - Projected Sales Volume|AMIX: Company Projected Revenue|INVO Bioscience, Inc. (IVF) - Company Projected Revenue|BBLG (Bone Biologics Inc) - Company Projected Revenue|AXNX (Axonics, Inc.) - Projected Sales Volume|biolase.com (BIOL) - Company Future Sales|Company Projected Revenue Dynatronics Corporation (DYNT)|Company Future Sales paragon28.com|Projected Sales Volume INVO (INVO Bioscience)
